Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Ghesquières H, Cherblanc F, Belot A, Micon S, Bouabdallah KK, Esnault C, Fornecker LM, Thokagevistk K, Bonjour M, Bijou F, Haioun C, Morineau N, Ysebaert L, Damaj G, Tessoulin B, Guidez S, Morschhauser F, Thiéblemont C, Chauchet A, Gressin R, Jardin F, Fruchart C, Labouré G, Fouillet L, Lionne-Huyghe P, Bonnet A, Lebras L, Amorim S, Leyronnas C, Olivier G, Guieze R, Houot R, Launay V, Drénou B, Fitoussi O, Detourmignies L, Abraham J, Soussain C, Lachenal F, Pica GM, Fogarty P, Cony-Makhoul P, Bernier A, Le Guyader-Peyrou S, Monnereau A, Boissard F, Rossi C, Camus V. Ghesquières H, et al. Among authors: fogarty p. Blood Adv. 2024 Jan 23;8(2):296-308. doi: 10.1182/bloodadvances.2023010798. Blood Adv. 2024. PMID: 37874913 Free PMC article.
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
Camus V, Thieblemont C, Gaulard P, Cheminant M, Casasnovas RO, Ysebaert L, Damaj GL, Guidez S, Pica GM, Kim WS, Lim ST, Andre M, Gutiérrez N, Penarrubia MJ, Staber PB, Trotman J, Hüttmann A, Stefoni V, Tucci A, Fogarty P, Farhat H, Abraham J, Abarah W, Belmecheri F, Ribrag V, Delfau-Larue MH, Cottereau AS, Itti E, Li J, Delarue R, de Leval L, Morschhauser F, Bachy E. Camus V, et al. Among authors: fogarty p. J Clin Oncol. 2024 May 10;42(14):1612-1618. doi: 10.1200/JCO.23.01687. Epub 2024 Feb 16. J Clin Oncol. 2024. PMID: 38364196 Clinical Trial.
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma.
Sesques P, Kirkwood AA, Kwon M, Rejeski K, Jain MD, Di Blasi R, Brisou G, Gros FX, le Bras F, Bories P, Choquet S, Rubio MT, Iacoboni G, O'Reilly M, Casasnovas RO, Bay JO, Mohty M, Joris M, Abraham J, Castilla Llorente C, Loschi M, Carras S, Chauchet A, La Rochelle LD, Hermine O, Guidez S, Cony-Makhoul P, Fogarty P, Le Gouill S, Morschhauser F, Gastinne T, Cartron G, Subklewe M, Locke FL, Sanderson R, Barba P, Houot R, Bachy E. Sesques P, et al. Among authors: fogarty p. J Hematol Oncol. 2024 Aug 6;17(1):61. doi: 10.1186/s13045-024-01579-w. J Hematol Oncol. 2024. PMID: 39107847 Free PMC article.
Precautions to Consider in the Analysis of Prognostic and Predictive Indices.
Chartier L, Belot A, Chaillol I, Elsensohn MH, Portugues C, Fournier M, Joubert C, Gat E, Pizot C, Fogarty P, Murairi T, Ammar RO, Paget J, Cherblanc F, Ricci R, Vercellino L, Kanoun S, Cottereau AS, Thieblemont C, Casasnovas O. Chartier L, et al. Among authors: fogarty p. J Nucl Med. 2024 Nov 1;65(11):1672-1678. doi: 10.2967/jnumed.123.267021. J Nucl Med. 2024. PMID: 39486863
The Roadmap to Integrate Diversity, Equity, and Inclusion in Hematology Clinical Trials: An American Society of Hematology Initiative.
Kuaban A, Croker A, Keefer J, Valentino LA, Bierer BE, Boateng S, DiMichele DM, Fogarty P, Gibson MC, Hood AM, Hubbard L, Isgrò A, Knobe K, Lake L, Martin I, Reid MM, Roberts JC, Tomlinson W, Tunji-Ajayi L MSM, Van Spall H, Voltz-Girolt CH, Wheeler AP, Mast AE, Seremetis S. Kuaban A, et al. Among authors: fogarty p. Blood Adv. 2024 Dec 9:bloodadvances.2024013945. doi: 10.1182/bloodadvances.2024013945. Online ahead of print. Blood Adv. 2024. PMID: 39652409
Coronary artery calcification detected on low-dose computed tomography in high-risk participants of an Australian lung cancer screening program: A prospective observational study.
Bonney A, Chua M, McCusker MW, Pascoe D, Joshi SB, Steinfort D, Marshall H, Silver JD, Xie C, Yang S, Watson J, Fogarty P, Stone E, Brims F, McWilliams A, Hu X, Rofe C, Milner B, Lam S, Fong KM, Manser R. Bonney A, et al. Among authors: fogarty p. Respirology. 2025 Jan;30(1):62-69. doi: 10.1111/resp.14832. Epub 2024 Sep 24. Respirology. 2025. PMID: 39318183 Free PMC article.
A common curriculum in obstetrics and gynecology for medical students globally.
Atiomo WU, Casper G, Symonds I, Obermair HM, Gwako G, Vash-Margita A, Sosa C, Kihara A, Ezimokhai M, Fogarty P. Atiomo WU, et al. Among authors: fogarty p. Int J Gynaecol Obstet. 2024 Oct;167(1):191-196. doi: 10.1002/ijgo.15544. Epub 2024 Apr 26. Int J Gynaecol Obstet. 2024. PMID: 38666747
A Prospective Observational Study of Physical Activity Levels and Physical Fitness of People at High Risk for Lung Cancer.
Bonney A, Granger CL, Steinfort D, Marshall HM, Stone E, McWilliams A, Brims F, Fogarty P, Lin L, Li J, Pang S, Lam S, Fong KM, Manser R. Bonney A, et al. Among authors: fogarty p. JTO Clin Res Rep. 2024 Jan 13;5(2):100633. doi: 10.1016/j.jtocrr.2024.100633. eCollection 2024 Feb. JTO Clin Res Rep. 2024. PMID: 38371193 Free PMC article.
117 results